12:00 AM
 | 
Oct 04, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

XTL001: Began Phase II testing

XTL Biopharmaceuticals Ltd., Rehovot, Israel
Product: XTL001
Business: Infectious diseases
Therapeutic category: Viral infection
Target:...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >